US Patent Issued to The Chinese University of Hong Kong on Feb. 18 for "Determining a nucleic acid sequence imbalance associated with cancer using multiple markers" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,804, issued on Feb. 18, was assigned to The Chinese University of Hong Kong (Shatin, Hong Kong).

"Determining a nucleic acid sequence imbalance associated with cancer using multiple markers" was invented by Yuk-Ming Dennis Lo (Kowloon, China), Rossa Wai Kwun Chiu (Shatin, China), Kwan Chee Chan (Shatin, China), Benny Chung Ying Zee (Ma On Shan, China) and Ka Chun Chong (Tai Po, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, systems, and apparatus are provided for determining whether a nucleic acid sequence imbalance exists within a biological sample. One or more cutoff values for determining an imbalance of, for example, the ratio of ...